MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
719.10%
Quick Ratio
674.40%
Debt to Asset Ratio
142.83%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Right-of-use assets, net
    • Prepaid expenses and other curre...
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Liability related to the sale of...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
98,490
110,734
121,169
129,063
Trade and other receivables, net
9,326
6,867
17,763
11,801
Inventories
7,366
8,066
6,169
7,884
Prepaid expenses and other current assets
3,312
4,516
4,168
2,925
Total current assets
118,494
130,183
149,269
151,673
Property and equipment, net
3,960
3,839
3,893
3,918
Right-of-use assets, net
7,949
4,468
4,621
4,769
Other non-current assets
1,701
2,635
2,642
3,199
Total assets
132,104
141,125
160,425
163,559
Accounts payable
8,965
11,889
29,862
10,865
Accrued expenses
4,518
3,449
5,029
5,128
Lease liabilities, current
820
662
631
601
Deferred revenue, current
1,092
1,092
1,092
1,092
Liability related to the sale of future revenue, current
1,000
1,000
1,000
1,000
Royalty obligations, current
51
-
0
561
Loans payable, current
-
13,661
9,994
6,327
Debt, current
32
-
-
-
Total current liabilities
16,478
31,753
47,608
25,574
Debt, long-term, net
50,654
25,099
27,519
-
Notes payable, net
-
-
-
29,940
Royalty obligations, net
27,835
26,914
25,941
23,948
Liability related to the sale of future revenue, net
61,168
62,083
62,023
61,977
Lease liabilities
7,525
4,159
4,337
4,508
Deferred revenue, net of current portion
18,845
19,118
19,390
19,663
Other non-current liabilities
6,185
6,053
7,269
2,058
Total liabilities
188,690
175,179
194,087
167,668
Common stock, 0.001 par value. authorized 250,000,000 shares 125,511,648 and 122,044,299 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
126
124
122
121
Additional paid-in capital
421,207
420,877
413,214
410,908
Accumulated deficit
-477,919
-455,055
-446,998
-415,138
Total stockholders deficit
-56,586
-34,054
-33,662
-4,109
Total liabilities and stockholders deficit
132,104
141,125
160,425
163,559
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$98,490K (62.70%↑ Y/Y)Trade and otherreceivables, net$9,326K (-21.39%↓ Y/Y)Inventories$7,366K (-9.34%↓ Y/Y)Prepaid expenses andother current assets$3,312K (176.92%↑ Y/Y)Total current assets$118,494K (45.00%↑ Y/Y)Right-of-use assets, net$7,949K (61.86%↑ Y/Y)Property and equipment,net$3,960K (2.64%↑ Y/Y)Other non-currentassets$1,701K (-46.98%↓ Y/Y)Total assets$132,104K (40.99%↑ Y/Y)Accumulated deficit-$477,919K (-19.57%↓ Y/Y)Total liabilities andstockholders deficit$132,104K (40.99%↑ Y/Y)Total stockholdersdeficit-$56,586K (22.05%↑ Y/Y)Additional paid-in capital$421,207K (28.81%↑ Y/Y)Common stock, 0.001 parvalue. authorized...$126K (27.27%↑ Y/Y)Total liabilities$188,690K (13.47%↑ Y/Y)Liability related to thesale of future...$61,168K (-1.22%↓ Y/Y)Debt, long-term, net$50,654K Royalty obligations,net$27,835K (22.56%↑ Y/Y)Deferred revenue, net ofcurrent portion$18,845K (-5.47%↓ Y/Y)Total currentliabilities$16,478K (-28.84%↓ Y/Y)Lease liabilities$7,525K (61.20%↑ Y/Y)Other non-currentliabilities$6,185K (201.41%↑ Y/Y)Accounts payable$8,965K (-24.99%↓ Y/Y)Accrued expenses$4,518K (-9.66%↓ Y/Y)Deferred revenue,current$1,092K (0.00%↑ Y/Y)Liability related to thesale of future...$1,000K (0.00%↑ Y/Y)Lease liabilities,current$820K (43.86%↑ Y/Y)Royalty obligations,current$51K (-85.99%↓ Y/Y)Debt, current$32K

Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics, Inc. (AQST)